Trends in Medicare Spending on Oral Drugs for Chronic Lymphocytic Leukemia From 2014 to 2020

This cross-sectional study analyzes trends in Medicare Part D use and spending on oral-targeted drugs for chronic lymphocytic leukemia from 2014 to 2020.

Detalles Bibliográficos
Autores principales: Cliff, Edward R. Scheffer, Kesselheim, Aaron S., Rome, Benjamin N., Feldman, William B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082405/
https://www.ncbi.nlm.nih.gov/pubmed/37027159
http://dx.doi.org/10.1001/jamanetworkopen.2023.7467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082405/
https://www.ncbi.nlm.nih.gov/pubmed/37027159
http://dx.doi.org/10.1001/jamanetworkopen.2023.7467

Ejemplares similares